Suppr超能文献

植入前基因诊断在平衡易位携带者中的作用。

The role for preimplantation genetic diagnosis in balanced translocation carriers.

作者信息

Sampson Jone E, Ouhibi Nadia, Lawce Helen, Patton Phillip E, Battaglia David E, Burry Kenneth A, Olson Susan B

机构信息

Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, 97239-3011, USA.

出版信息

Am J Obstet Gynecol. 2004 Jun;190(6):1707-11; discussion 1711-3. doi: 10.1016/j.ajog.2004.02.063.

Abstract

OBJECTIVE

Preimplantation genetic diagnosis is an established technique that provides an alternative to prenatal diagnosis for patients who are at risk of transmitting a serious genetic disorder to their offspring. Preimplantation genetic diagnosis has been used for couples who have been at risk for having offspring with single gene or X-linked disorders and for screening for common age-related aneuploidy and in couples who themselves carry balanced chromosomal rearrangements. The aim of this study was to summarize our experience using preimplantation genetic diagnosis after the identification of a parental balanced translocation, specifically as it relates to the number of embryos that are suitable for transfer after preimplantation genetic diagnosis for a known translocation and aneuploidy screening.

STUDY DESIGN

This is a retrospective review of data from a single center that involved 6 couples that initiated the process of preimplantation genetic diagnosis for translocation and aneuploidy screening by fluorescent in situ hybridization.

RESULTS

A total of 65 embryos were obtained, of which 56 embryos (86%) were suitable for fluorescent in situ hybridization analysis. After fluorescent in situ hybridization, 1 embryo was diagnosed as normal or balanced (1.7%). Forty-three embryos (76.8%) were unbalanced for the translocation; 8 embryos (14.3%) were aneuploid, and 4 embryos (7.1%) were uninformative. There were no clinical pregnancies.

CONCLUSION

In our experience, there are very few embryos that are available for transfer from these patients after translocation and aneuploidy screening because of multiple unbalanced segregation products and a high rate of aneuploidy. Factors that contributed to this may be related to which parent carries the translocation, methods that were used for in vitro fertilization, and advanced maternal age. Although preimplantation genetic diagnosis for translocation carriers theoretically can enhance the pregnancy rate for a couple, there are limitations. This information should be shared with couples who are contemplating preimplantation genetic diagnosis for translocation, and the options of sperm or egg donor should be considered.

摘要

目的

植入前基因诊断是一项成熟的技术,为有将严重遗传疾病传给后代风险的患者提供了一种替代产前诊断的方法。植入前基因诊断已用于有生育单基因或X连锁疾病后代风险的夫妇,用于筛查常见的年龄相关非整倍体,以及用于自身携带平衡染色体重排的夫妇。本研究的目的是总结我们在识别亲本平衡易位后使用植入前基因诊断的经验,特别是与已知易位和非整倍体筛查的植入前基因诊断后适合移植的胚胎数量相关的经验。

研究设计

这是一项对来自单一中心的数据的回顾性研究,该中心有6对夫妇通过荧光原位杂交启动了用于易位和非整倍体筛查的植入前基因诊断过程。

结果

共获得65个胚胎,其中56个胚胎(86%)适合进行荧光原位杂交分析。荧光原位杂交后,1个胚胎被诊断为正常或平衡(1.7%)。43个胚胎(76.8%)易位不平衡;8个胚胎(14.3%)为非整倍体,4个胚胎(7.1%)信息不明确。无临床妊娠。

结论

根据我们的经验,由于多种不平衡分离产物和高非整倍体率,这些患者在易位和非整倍体筛查后可用于移植的胚胎非常少。导致这种情况的因素可能与携带易位的亲本、用于体外受精的方法以及产妇年龄较大有关。尽管理论上易位携带者的植入前基因诊断可以提高夫妇的妊娠率,但仍存在局限性。应将此信息告知考虑进行易位植入前基因诊断的夫妇,并应考虑精子或卵子捐赠者的选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验